United States · FDA National Drug Code directory

Lisinopril and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 76282-447_7f4a4f31-58b0-4fe1-bd11-ba5a6ac4f26c
Product NDC: 76282-447
Form: TABLET
Composition / generic term: Lisinopril and Hydrochlorothiazide Tablets
Labeler: Exelan Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190501
Source listing expiry: 20261231

Source-listed ingredients

LISINOPRIL — 20 mg/1
HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (76282-447-01) · 76282-447-01
500 TABLET in 1 BOTTLE (76282-447-05) · 76282-447-05
1000 TABLET in 1 BOTTLE (76282-447-10) · 76282-447-10
90 TABLET in 1 BOTTLE (76282-447-90) · 76282-447-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →